What is Korsana Biosciences, Inc.?
develops therapeutic antibodies for the treatment of neurodegenerative diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.71B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.